Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alisartan ester tablets in mild to moderate primary hypertension
CTR20160138Phase 4Completed
- Sponsor
- Allist Pharmaceuticals
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alisartan in essential hypertension, sponsored by Allist Pharmaceuticals. Started Sep 2016; status: completed.
02
Drugs
alisartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20160138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160138.